Skip to main content
. 2014 Mar 18;9(3):e91502. doi: 10.1371/journal.pone.0091502

Figure 7. The abundance of mutants in the cell vs. the increasing concentration of BILN-2061 (a) and VX-950 (b) inhibitors.

Figure 7